Q3 2021 13F Holders as of 30 Sep 2021
-
Type / Class
-
Equity / Common Stock, $0.001 par value
-
Shares outstanding
-
55,482,166
-
Number of holders
-
63
-
Total 13F shares, excl. options
-
22,241,759
-
Shares change
-
-1,202,211
-
Total reported value, excl. options
-
$58,623,539
-
Value change
-
-$4,030,195
-
Put/Call ratio
-
57.4%
-
Number of buys
-
22
-
Number of sells
-
-47
-
Price
-
$2.63
Significant Holders of Voyager Therapeutics, Inc. - Common Stock, $0.001 par value (VYGR) as of Q3 2021
83 filings reported holding VYGR - Voyager Therapeutics, Inc. - Common Stock, $0.001 par value as of Q3 2021.
Voyager Therapeutics, Inc. - Common Stock, $0.001 par value (VYGR) has 63 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 22,241,759 shares
of 55,482,166 outstanding shares and own 40.1% of the company stock.
Largest 10 shareholders include TRV GP III, LLC (6,391,176 shares), ARMISTICE CAPITAL, LLC (3,716,000 shares), VANGUARD GROUP INC (2,162,874 shares), CITADEL ADVISORS LLC (982,824 shares), Erste Asset Management GmbH (962,900 shares), BlackRock Inc. (930,735 shares), JPMORGAN CHASE & CO (784,003 shares), ACADIAN ASSET MANAGEMENT LLC (771,975 shares), FEDERATED HERMES, INC. (719,448 shares), and MORGAN STANLEY (616,852 shares).
This table shows the top 63 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.